C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/11 (2006.01) A61K 35/28 (2006.01) A61K 48/00 (2006.01) C07K 14/16 (2006.01) C12N 5/10 (2006.01) C12N 15/49 (2006.01) C12N 15/86 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2254819
Novel antisense sequences to the unspliced or single spliced portions of mRNA transcript from HIV-1 provirus, optionally co-expressed with an inhibitory transdominant mutant HIV-1 protein, are found to be useful in the treatment of HIV-1 infection.
L'invention concerne des nouvelles séquences antisens ayant pour cible des portions à épissage simple ou non épissées d'un produit de transcription d'ARNm provenant du provirus du VIH de type 1 (VIH-1), éventuellement exprimées en même temps qu'une protéine du VIH-1 mutante, transdominante et inhibitrice. Ces séquences sont utiles dans le traitement de l'infection à VIH-1.
Boehnlein Ernst
Escaich Sonia
Ilves Heini
Veres Gabor
Fetherstonhaugh & Co.
Novartis Ag
Systemix Inc.
LandOfFree
Inhibition of hiv-1 replication by antisense rna expression does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of hiv-1 replication by antisense rna expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of hiv-1 replication by antisense rna expression will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1503836